Ways To Help Skip Navigation Links

Research Skip Navigation Links

About TGen Foundation Skip Navigation Links

TGen News

TGen Web Site

PROSTATE CANCER

Prostate Cancer is a deadly disease that is expected to take the lives of over 27,000 American men this year. It is estimated that more than 192,000 new cases will be diagnosed in 2009. Prostate cancer is the most common cancer and the second leading cause of cancer death in men.

In about 75 percent of cases, prostate cancer arises sporadically. About 15-20 percent of cases have a familial or environmental component and in the remaining 5-10 percent of cases, prostate cancer is inherited—caused by mutations in genes that are passed down from generation to generation.

Evidence suggests that men who are genetically prone to the disease tend to have more aggressive and often more fatal cancers than men who are not. Because there is no way to tell whether a person has the aggressive version or the mild version of prostate cancer, both forms are treated the same—with chemotherapy or surgery to remove the prostate gland. Because of prostate cancer's high incidence and impact on quality of life, it would be beneficial if physicians could determine who is at risk for developing this disease and prevent it.

 

There are few prostate cancer-specific drugs available even after decades of research. TGen's mission is to accelerate the search for genes that cause prostate cancer and discover potential new drug targets.

Researchers at TGen are focused on searching for genetic identifiers that will act as predictors for prostate cancer. TGen is currently conducting the most in-depth study of its kind designed to scan the genomes of 112 families with prostate cancer to identify genetic risk factors for the disease. Once these risk factors are identified, scientists can use that information to develop diagnostic and prognostic tools to help physicians treat their patients.

 


CANCER PROGRAMS Skip Navigation Links
Adrenocortical Cancer
Brain Tumors
Breast Cancer
Colon Cancer
Liver Cancer
Lung Cancer
Melanoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer

 

RELATED LINKS

Cancer Gene Discovery and Molecular Validation Unit at TGen

Dr. John Carpten

Your donation in support of Prostate Cancer research at TGen is important to furthering the institute's mission to develop earlier diagnoses and smarter treatments for patients.

Volunteer! Become a TGen Ambassador and help raise funds in your community for Prostate Cancer research.

To discuss ways to become involved and support cancer research at TGen, contact the TGen Foundation at Foundation@tgen.org, or call 602.343.8411.